OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
Kimberley L. Kaufman, Swetlana Mactier, Nicola J. Armstrong, et al.
Clinical & Experimental Metastasis (2014) Vol. 31, Iss. 4, pp. 407-421
Open Access | Times Cited: 9

Showing 9 citing articles:

Advances in Immunotherapy for Melanoma: A Comprehensive Review
Carmen Rodríguez‐Cerdeira, Miguel Carnero-Gregorio, Adriana López-Bárcenas, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-14
Open Access | Times Cited: 118

Critical Assessment of Clinical Prognostic Tools in Melanoma
Alyson Mahar, Carolyn C. Compton, Susan Halabi, et al.
Annals of Surgical Oncology (2016) Vol. 23, Iss. 9, pp. 2753-2761
Closed Access | Times Cited: 46

The tumour immune landscape and its implications in cutaneous melanoma
Grace H. Attrill, Peter M. Ferguson, Umaimainthan Palendira, et al.
Pigment Cell & Melanoma Research (2020) Vol. 34, Iss. 3, pp. 529-549
Open Access | Times Cited: 33

Detection of circulating tumor cells is achieved by flow cytometry in melanoma patients
Ludivine Fourdrain, Théo Brochet, Valentin Clichet, et al.
Cytometry Part B Clinical Cytometry (2025)
Open Access

Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy
Meredith McKean, Rodabe N. Amaria
Cancer Treatment Reviews (2018) Vol. 70, pp. 144-153
Open Access | Times Cited: 33

KLF4 suppresses anticancer effects of brusatol via transcriptional upregulating NCK2 expression in melanoma
Xiaodong Li, Yuankuan Jiang, Ying Wang, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116197-116197
Closed Access | Times Cited: 2

Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response
Alexis E. Carey, Ashani T. Weeraratna
Pharmacology & Therapeutics (2024) Vol. 262, pp. 108698-108698
Closed Access | Times Cited: 1

Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1
Hauke Thomsen, Subhayan Chattopadhyay, Per Hoffmann, et al.
Melanoma Research (2019) Vol. 30, Iss. 2, pp. 166-172
Closed Access | Times Cited: 10

Antibody-drug conjugates: an evolving approach for melanoma treatment
Trevor S. Anderson, Amanda L. Wooster, Ninh M. La‐Beck, et al.
Melanoma Research (2020) Vol. 31, Iss. 1, pp. 1-17
Closed Access | Times Cited: 7

Page 1

Scroll to top